PEPG FY 2024 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$98M

Net Income

-$90M

EPS (Diluted)

$-2.85

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$83M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$151M

Total Liabilities

$32M

Stockholders' Equity

$119M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$1M	-27.1%
Operating Income	-$98M	-$85M	-15.3%
Net Income	-$90M	-$79M	-14.4%